New methods for covariate adjustment improve statistical efficiency in randomized clinical trials, suggesting broader applicability and consistency.
Covariate adjustment aims to improve the statistical efficiency of randomized trials by incorporating information from baseline covariates. Popular methods for covariate adjustment include analysis of covariance for continuous endpoints and standardized logistic regression for binary endpoints. For survival endpoints, while some covariate adjustment methods have been developed for specific effect measures, they are not commonly used in practice for various reasons, including high demands for theoretical and methodological sophistication as well as computational skills. This article describes an augmentation approach to covariate adjustment for survival endpoints that is relatively easy to understand and widely applicable to different effect measures. This approach involves augmenting a given treatment effect estimator in a way that preserves consistency and asymptotic normality under minimal assumptions (i.e., randomization). It does not attempt to exploit other possible constraints (e.g., independent censoring, proportional hazards) on the observed data distribution. The optimal augmentation term, which minimizes the asymptotic variance of an augmented estimator, can be estimated using various statistical and machine learning methods. Simulation results demonstrate that the augmentation approach can bring substantial gains in statistical efficiency. This approach has been implemented in an R package named sleete , which is described in detail and illustrated with real data.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: